4

FORM 4 SUBMISSION

Company: MADRIGAL PHARMACEUTICALS, INC.
Filed: March 11, 2019
Period of Report: March 7, 2019
Accession Number: 0000899243-19-007019

View Document ↗ View on SEC.gov ↗